Risk factors associated with the development of peripheral arterial disease in smokers: A case-control study

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 41-48

  Powell, Janet T ^a   Edwards, Richard J ^a   Worrell, Phillip C ^a   Franks, Peter J ^a   Greenhalgh, Roger M ^a   Poulter, Neil R ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

apolipoprotein B; low tar cigarettes; peripheral atherosclerosis; smoking; systolic hypertension

Indexed keywords

APOLIPOPROTEIN B;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0031049578     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06012-1     Document Type: Article

References (28)

1. Juergens JL, Barker NW, Hines EA. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960;21:188-195.
2. Lord JW. Cigarette smoking and atherosclerosis occlusive disease. JAMA 1965;191:249-251.
3. Hughson WG, Mann JI, Garrod A. Intermittent claudication:prevalence and risk factors. BMJ 1978;1:1379-1381.
4. Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988;2:283-291.
5. Behague I, Poirir O, Nicaud V et al. β Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. Circulation 1996;93:440-449.
6. Margetts BM, Jackson AA. Interactions between people's diet and their smoking habits: the dietary and nutritional survey of British adults. Br Med J 1993;307:1381-1384.
7. Surgeon General. The health consequences of smoking. The changing cigarette. Rockville, Maryland, USA: US Department of Health and Human Services, 1989.
8. International Agency for Research on Cancer. Tobacco smoking. IARC Monograph Evaluating Carcinogen Risk to Humans, 1985 pp. 37-421.
9. Kaufman DW, Helmrich SP, Rosenberg L, Miettenen OS, Shapiro S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. New Engl J Med 1983;308:409-413.
10. Pettiti DB, Friedman GD. Cardiovascular and other diseases in smokers of low yield cigarettes. J Chron Dis 1985;48:581-588.
11. Palmer JR, Rosenberg L, Shapiro S. Low yield cigarettes and the risk of nonfatal myocardial infarction in women. New Engl J Med 1989;320:1569-1573.
12. Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili A, Tognoni G. Tar yield of cigarettes and risk of acute myocardial infarction. Br Med J 1993;306:1567-1570.
13. Colhoun H, Prescott-Clarke P, Dong W, Hedges B, Lampe F, Taylor A. In: Colhoun H and Prescott-Clarke P (eds). Health Survey for England 1994. London: HMSO, 1996.
14. Rose GA, Blackburn H. Cardiovascular survey methods. World Health Organization (Geneva) Monograph series No. 56: 1968.
15. European working group on critical leg ischaemia. Second European Consensus document on chronic critical leg ischaemia. Circulation 1991;84(Suppl IV):1-26.
16. Yarnell JWG, Felicity AM, Milbank JE, Sweetman PM, Walker CL. A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr Appl Nutr 1983;37A:103-112.
17. Butts WC, Kuehmenan M, Widdowson GM. Automated method for determining serum thiocyanate to distinguish smokers from non-smokers. Clin Chem 1974;20:1344-1348.
18. Feyerabend C, Russell MAH. Rapid gas-liquid Chromatographic determination of cotinine in biological fluids. Analyst 1980;105:998-1001.
19. Wiseman S, Kenchington G, Dain R et al. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. Br Med J 1989;299:643-646.
20. SPSS Incorporated. SPSS Reference Guide. Chicago: SPSS Inc, 1990.
21. Sillet R, Wilson MB, Malcolm RE, Ball KP. Deception among smokers. Br Med J 1978;65:197-200.
22. Rutan GH, Kuller LH, Neaton JD, Wentworth DH, McDonald RH, McFate Smith W. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988;77:504-514.
23. Leng GC and Fowkes FGR. Lipids: Epidemiology: In Fowkes FGRE (ed). Epidemiology of Peripheral Vascular Disease. London: Springer-Verlag, 1991.
24. Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. BMJ 1986;293:1137-1139.
25. Davey-Smith G, Shipley M, Rose G. Intermittent claudication, heart disease risk factors and mortality: the Whitehall Study. Circulation 1990;82:1925-1931.
26. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. New Engl J Med 1992;326:381-386.
27. Fowkes FGR, Housley E, Riemersma RA et al. Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-340.
28. Greenhalgh RM, Lewis B, Rosengarten DS, Mevart I, Calnan JS, Martin P. Serum lipids and lipoproteins in peripheral vascular disease. Lancet 1971;ii:947-950.